相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Classification of Plasma Cell Disorders by 21 Tesla Fourier Transform Ion Cyclotron Resonance Top-Down and Middle-Down MS/MS Analysis of Monoclonal Immunoglobulin Light Chains in Human Serum
Lidong He et al.
ANALYTICAL CHEMISTRY (2019)
MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins
Lauren M. Moore et al.
CLINICA CHIMICA ACTA (2019)
Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry
Lusia Sepiashvili et al.
CLINICAL CHEMISTRY (2019)
Nanoporous silica coupled MALDI-TOF MS detection of Bence-Jones proteins in human urine for diagnosis of multiple myeloma
Shuping Long et al.
TALANTA (2019)
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
C. S. Chim et al.
LEUKEMIA (2018)
Screening and Diagnosis of Monoclonal Gammopathies An International Survey of Laboratory Practice
Jonathan R. Genzen et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference
John R. Mills et al.
BLOOD (2018)
Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
Maria A. V. Willrich et al.
CLINICAL BIOCHEMISTRY (2018)
Recognition and management of common, rare, and novel serum protein electrophoresis and immunofixation interferences
Christopher R. McCudden et al.
CLINICAL BIOCHEMISTRY (2018)
Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood
Kazunori Murata et al.
CLINICAL BIOCHEMISTRY (2018)
Resolution of Spurious Immunonephelometric IgG Subclass Measurement Discrepancies by LC-MS/MS
Grace van der Gugten et al.
CLINICAL CHEMISTRY (2018)
Nonsecretory and Light Chain Escape in Patients With Multiple Myeloma
Urmeel H. Patel et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2018)
Development of a Targeted Mass-Spectrometry Serum Assay To Quantify M-Protein in the Presence of Therapeutic Monoclonal Antibodies
Marina Zajec et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Circulating Tumour DNA for Detecting Minimal Residual Disease in Multiple Myeloma
Trevor J. Pugh
SEMINARS IN HEMATOLOGY (2018)
Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease
Katie L. Thoren
SEMINARS IN HEMATOLOGY (2018)
MASS-FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms
Taxiarchis Kourelis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma
Aurore Perrot et al.
BLOOD (2018)
A targeted proteomics approach to amyloidosis typing
Matteo Conti et al.
CLINICAL MASS SPECTROMETRY (2018)
Molecular detection of minimal residual disease in multiple myeloma
Yinlei Bai et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Standardisation of minimal residual disease in multiple myeloma
V. Innao et al.
EUROPEAN JOURNAL OF CANCER CARE (2017)
Analysis of Monoclonal Antibodies in Human Serum as a Model for Clinical Monoclonal Gammopathy by Use of 21 Tesla FT-ICR Top-Down and Middle-Down MS/MS
Lidong He et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2017)
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates
Olena Kis et al.
NATURE COMMUNICATIONS (2017)
High sensitivity blood-based M-protein detection in sCR patients with multiple myeloma
J. R. Mills et al.
BLOOD CANCER JOURNAL (2017)
The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic
Paolo Milani et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Mass Spectrometry Approaches for Identification and Quantitation of Therapeutic Monoclonal Antibodies in the Clinical Laboratory
Paula M. Ladwig et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Clinical mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?
Sylvain Lehmann et al.
CLINICA CHIMICA ACTA (2017)
Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration
H. Robert Bergen et al.
CLINICAL CHEMISTRY (2016)
Effective Use of Mass Spectrometry in the Clinical Laboratory
Paul J. Jannetto et al.
CLINICAL CHEMISTRY (2016)
What is new in diagnosis and management of light chain amyloidosis?
Giovanni Palladini et al.
BLOOD (2016)
Monoclonal gammopathy: The good, the bad and the ugly
Siobhan V. Glavey et al.
BLOOD REVIEWS (2016)
Fast, robust and high-resolution glycosylation profiling of intact monoclonal IgG antibodies using nanoLC-chip-QTOF
Joannes F. M. Jacobs et al.
CLINICA CHIMICA ACTA (2016)
Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry
John R. Mills et al.
CLINICAL CHEMISTRY (2016)
Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry
Mindy C. Kohlhagen et al.
CLINICAL CHEMISTRY (2016)
Challenges of measuring monoclonal proteins in serum
David F. Keren et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation
Maria Alice V. Willrich et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Is accuracy of serum free light chain measurement achievable?
Joannes F. M. Jacobs et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Monitoring free light chains in serum using mass spectrometry
David R. Barnidge et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference
Christopher McCudden et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA)
Niels W. C. J. van de Donk et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry
Peter Mollee et al.
CLINICAL PROTEOMICS (2016)
Quantitative Measurement of Immunoglobulins and Free Light Chains Using Mass Spectrometry
Martijn M. VanDuijn et al.
ANALYTICAL CHEMISTRY (2015)
New criteria for response assessment: role of minimal residual disease in multiple myeloma
Bruno Paiva et al.
BLOOD (2015)
Proteomic Detection of Immunoglobulin Light Chain Variable Region Peptides from Amyloidosis Patient Biopsies
Surendra Dasari et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Clarification of the definition of complete response in multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2015)
Detecting monoclonal immunoglobulins in human serum using mass spectrometry
John R. Mills et al.
METHODS (2015)
Minimal residual disease in multiple myeloma: bringing the bench to the bedside
Sham Mailankody et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to detect monoclonal immunoglobulin light chains in serum and urine
David R. Barnidge et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2015)
Proteomics and mass spectrometry in the diagnosis of renal amyloidosis
Maria M. Picken
CLINICAL KIDNEY JOURNAL (2015)
Curing myeloma at last: defining criteria and providing the evidence
Bart Barlogie et al.
BLOOD (2014)
Detecting monoclonal light chains in urine: microLC-ESI-Q-TOF mass spectrometry compared to immunofixation electrophoresis
Chad M. Botz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Quantification of Serum IgG Subclasses by Use of Subclass-Specific Tryptic Peptides and Liquid Chromatography-Tandem Mass Spectrometry
Paula M. Ladwig et al.
CLINICAL CHEMISTRY (2014)
Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics
Julie A. Vrana et al.
HAEMATOLOGICA (2014)
Monitoring M-Proteins in Patients with Multiple Myeloma Using Heavy-Chain Variable Region Clonotypic Peptides and LC-MS/MS
David R. Barnidge et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Using Mass Spectrometry to Monitor Monoclonal Immunoglobulins in Patients with a Monoclonal Gammopathy
David R. Barnidge et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry
David R. Barnidge et al.
JOURNAL OF PROTEOME RESEARCH (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patients
Elizabeth R. Remily-Wood et al.
PROTEOMICS CLINICAL APPLICATIONS (2014)
Characterization of immunoglobulin by mass spectrometry with applications for the clinical laboratory
David Murray et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2013)
Amyloid Formation in Light Chain Amyloidosis
Marina Ramirez-Alvarado
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Technology trends in antibody purification
Pete Gagnon
JOURNAL OF CHROMATOGRAPHY A (2012)
Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics
Amelia C. Peterson et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions
Paola Picotti et al.
NATURE METHODS (2012)
An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions
Lennard J. M. Dekker et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
S. Vincent Rajkumar et al.
BLOOD (2011)
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
Meletios Dimopoulos et al.
BLOOD (2011)
Long-Term Biological Variation of Serum Protein Electrophoresis M-Spike, Urine M-Spike, and Monoclonal Serum Free Light Chain Quantification: Implications for Monitoring Monoclonal Gammopathies
Jerry A. Katzmann et al.
CLINICAL CHEMISTRY (2011)
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
R. A. Kyle et al.
LEUKEMIA (2010)
Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens
Julie A. Vrana et al.
BLOOD (2009)
Quantitation of Serum Monoclonal Proteins: Relationship between Agarose Gel Electrophoresis and Immunonephelometry
David L. Murray et al.
CLINICAL CHEMISTRY (2009)
Screening Panels for Detection of Monoclonal Gammopathies
Jerry A. Katzmann et al.
CLINICAL CHEMISTRY (2009)
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
Andy C. Rawstron et al.
HAEMATOLOGICA (2008)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
分享论文
